InvestorsHub Logo
Followers 2
Posts 32
Boards Moderated 0
Alias Born 01/18/2012

Re: Dip66 post# 35423

Thursday, 04/17/2014 7:09:04 PM

Thursday, April 17, 2014 7:09:04 PM

Post# of 50672
Here is the Fb post, and it is encouraging!

MultiCell Technologies, Inc.
3 hours ago
MultiCell's majority-owned subsidiary, Xenogenics, OWNS the Ideal TM bio-stent technology outright. Xenogenics has a license with Rutgers for one component of intellectual property for an add-on to the stent which may or may not even be important, but Xenogenics has been evaluating it for potential use on the stent.
Like · · Share
Top Comments
8 people like this.